[Participation of damage-associated molecular patterns in conventional treatment of cancer]

Verónica Rojo-León1, Dolores Aguilar-Cázares, Heriberto Prado-García

  • 1Laboratorio de Cáncer Pulmonar, Unidad de Investigación, Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas.

Insights

Immunogenic apoptosis, a form of cell death, is crucial for anti-tumor immunity. Cancer therapies can induce this cell death, releasing danger signals that activate immune responses against tumors.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Context:

  • Innate immune cells distinguish between homeostatic apoptosis and damage-induced necrosis.
  • Immunogenic apoptosis, a distinct cell death pathway, is increasingly recognized for its role in cancer.

Purpose:

  • To review the significance of immunogenic apoptosis in cancer.
  • To discuss cytotoxic drugs that induce this cell death pathway.
  • To explore the biological role of damage-associated molecular patterns (DAMPs) in activating anti-tumor immunity.

Summary:

  • Radiotherapy and chemotherapy can trigger immunogenic apoptosis in cancer cells.
  • Dying cancer cells release DAMPs, which act as danger signals.
  • These DAMPs are critical for initiating an effective anti-tumor immune response, particularly involving phagocytic cells.

Impact:

  • Enhancing immune recognition and elimination of residual tumor cells.
  • Overcoming tumor cell evasion mechanisms.
  • Improving tumor growth control, reducing recurrence, and potentially increasing patient survival or achieving cures.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...